Bristol-Myers, which is based in New York and owns about 83 percent of Mead’s stock, expects the deal to add to earnings starting in 2010, The Associated Press reported. The company says the stock swap is designed to allow …
Bristol-Myers Squibb will purchase all the outstanding capital stock of Flexus in an initial investment of $800 million …
Bristol-Myers Squibb Co. shares edged up in premarket electronic trading today after a Goldman Sachs analyst upgraded the drug maker's stock because of its declining price. Bristol-Myers shares have been trading at annual lows over the …
Remember, Bristol-Myers Squibb's stock took a beating after blockbuster cancer immunotherapy drug Opdivo failed to even come close to reaching its primary endpoint in treatment-naive advanced non-small cell lung cancer (NSCLC) …
Analysts have increased the stock’s price target based on the company’s big year in clinical trial results. Bristol Myers Squibb shares were mostly flat during premarket trading Wednesday. The stock has increased 1.5% in the past year. …
NEW YORK, Nov 15 (Reuters) - Bristol-Myers Squibb Co (BMY.N) said on Sunday it plans to split off its 83 percent stake in Mead Johnson Nutrition Company MJN.N in a deal that lets Bristol shareholders exchange their shares for Mead …
Shares of Bristol-Myers Squibb Company BMY gained about 5% after the company ended its phase III combination study, CheckMate-214, earlier than expected after it met its co- primary endpoint. The phase III study evaluated Opdivo plus …
In addition, shareholders with beneficial ownership of approximately 17% of Inhibitex’s common stock have entered into agreements with Bristol-Myers Squibb to support the transaction and to tender their shares in the tender offer. …
NEW YORK (CNN/Money) - Bristol-Myers Squibb is battered black and blue, and it just got punched in the gut again. But one industry watcher thinks the drugmaker can retrace its way back from a series of management missteps and effect …
NEW YORK (Reuters) - Bristol-Myers Squibb Co (BMY.N) said on Sunday it plans to split off its 83 percent stake in Mead Johnson Nutrition Company MJN.N in a deal that lets Bristol shareholders exchange their shares for Mead Johnson …